[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370470-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370470-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","advances-in-tumor-subclone-formation-and-mechanisms-of-growth-and-invasion","Advances in tumor subclone formation and mechanisms of growth and invasion","","Tumor subclones are genetically distinct cell populations within the same tumor that shape tumor heterogeneity, evolution, and therapeutic resistance. Their emergence reflects tumor-cell genetic instability, microenvironmental and treatment selective pressures, and epigenetic regulation such as DNA methylation and histone modification. Single-cell sequencing, liquid biopsy, and spatial transcriptomics enable reconstruction of clonal architecture and dynamic evolution. The review links subclones to immune evasion, invasion, recurrence, and metastasis risk, and highlights how AI, big data, and multi-omics can accelerate precision oncology.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/advances-in-tumor-subclone-formation-and-mechanisms-of-growth-and-invasion/370470/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/advances-in-tumor-subclone-formation-and-mechanisms-of-growth-and-invasion/370470.png","ImageObject",300,407,{"name":42,"@type":43},"\tJames","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are tumor subclones and why do they matter?","Question",{"text":63,"@type":64},"Tumor subclones are genetically distinct cell populations within one tumor. They are central to understanding heterogeneity, evolutionary dynamics, and why tumors develop resistance to therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How are tumor subclones formed?",{"text":68,"@type":64},"Their formation is driven by genetic instability that accumulates mutations, selective pressures from the tumor microenvironment and therapies that expand certain subclones, and epigenetic modifications that reshape gene expression patterns.",{"name":70,"@type":61,"acceptedAnswer":71},"What methods are used to study tumor subclones?",{"text":72,"@type":64},"The review highlights single-cell sequencing, liquid biopsy, and spatial transcriptomics. These approaches help reconstruct clonal architecture, track subclonal dynamics, and identify key driver mutations.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370470,1790254192,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Zhang and Wang  \nJournal of Translational Medicine (2025) 23:461 [https://doi.org/10.1186/s12967-025-06486-3](https://doi.org/10.1186/s12967-025-06486-3)  \nJournal of Translational Medicine  \n REVIEW Open Access  \nAdvances in tumor subclone formation and mechanisms of growth and invasion  \nYuhong Zhang1,2 and Weidong Wang1,2*  \nAbstract  \nTumor subclones refer to distinct cell populations within the same tumor that possess different genetic characteristics. They play a crucial role in understanding tumor heterogeneity, evolution, and therapeutic resistance. The formation of tumor subclones is driven by several key mechanisms, including the inherent genetic instability of tumor cells, which facilitates the accumulation of novel mutations; selective pressures  \nfrom the tumor microenvironment and therapeutic interventions, which promote the expansion of certain subclones; and epigenetic modifications, such as DNA methylation and histone modifications, which alter gene expression patterns. Major methodologies for studying tumor subclones include single-cell sequencing, liquid biopsy, and spatial transcriptomics, which provide insights into clonal architecture and dynamic evolution. Beyond their direct involvement in tumor growth and invasion, subclones significantly contribute to tumor heterogeneity, immune evasion, and treatment resistance. Thus, an in-depth investigation of tumor subclones not only aids in guiding personalized precision therapy, overcoming drug resistance, and identifying novel therapeutic targets, but also enhances our ability to predict recurrence and metastasis risks while elucidating the mechanisms underlying tumor heterogeneity. The integration of artificial intelligence, big data analytics, and multi-omics technologies is expected to further advance research in tumor subclones, paving the way for novel strategies in cancer diagnosis and treatment. This review aims to provide a comprehensive overview of tumor subclone formation mechanisms, evolutionary models, analytical methods, and clinical implications, offering insights into precision oncology and future translational research.  \nKeywords Tumor subclones, Clonal evolution, Genomic instability, Intratumoral heterogeneity, Phylogenetic analysis, Multi-omics integration, Big data in oncology  \nBackground  \nTumor subclones refer to genetically distinct cell subpopulations within a single tumor that originate from a common ancestral cell. These subclones exhibit  \n*Correspondence: Weidong Wang [wwdwyl@sina.com](wwdwyl@sina.com)  \n1 Department of Oncology, Clinical Medical College, Southwest Medical University, No. 319, Section 3, Zhongshan Road, Luzhou 646099, Sichuan, China  \n2 Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, China  \nunique genomic or epigenomic characteristics, leading to variations in biological behavior and treatment responses.  \nDuring cellular proliferation, individual cancer cells gradually accumulate mutations, some of which confer survival advantages. These mutations drive the acquisition of hallmark traits of cancer, including rapid proliferation, immune evasion, and drug resistance [1].  \nIn the early stages of tumorigenesis, the accumulation of multiple driver mutations, such as those in KRAS, TP53, and SMAD4, is required to establish an ancestral cancer cell, which undergoes clonal expansion, giving rise to the initial cancer clone-the foundational population from which tumor subclones emerge [2]. Subsequent  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the sourc","cbCaim8HfLHoR1Iu","https://ap.wps.com/l/cbCaim8HfLHoR1Iu","pdf",1381046,12,"English","# Abstract\n# Background\n## Tumorigenesis and clonal expansion\n## Evolutionary forces and subclonal coexistence\n# Methodologies for subclonal analysis\n## High-throughput sequencing and spatial transcriptomics\n## Liquid biopsy\n# Clinical implications and future directions","[{\"question\":\"What are tumor subclones and why do they matter?\",\"answer\":\"Tumor subclones are genetically distinct cell populations within one tumor. They are central to understanding heterogeneity, evolutionary dynamics, and why tumors develop resistance to therapy.\"},{\"question\":\"How are tumor subclones formed?\",\"answer\":\"Their formation is driven by genetic instability that accumulates mutations, selective pressures from the tumor microenvironment and therapies that expand certain subclones, and epigenetic modifications that reshape gene expression patterns.\"},{\"question\":\"What methods are used to study tumor subclones?\",\"answer\":\"The review highlights single-cell sequencing, liquid biopsy, and spatial transcriptomics. These approaches help reconstruct clonal architecture, track subclonal dynamics, and identify key driver mutations.\"}]","Advances in tumor subclone formation and mechanisms of growth and invasion | PDF",1790188701,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b506f9e5b3963c554690a469d9f3f20e.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02cc5a5e8d5cc194696c866a38ffe297.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9c1dd190571cecdb1dedb852b877223.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd2e13451fc8c1f4cfd46482d53d9bb4.webp",980,1301]